The outcome of CLL patients with MYD88 mutations is highly controversial; some studies showed a favorable prognosis23,32 whereas others showed an unfavorable prognosis27, or no association with prognosis24,28. The gene discussed is MYD88; the disease is B-cell chronic lymphocytic leukemia.